Home Efficacy of rectal progesterone on maternal and neonatal outcomes in pregnant women with Preterm Premature Rupture of membranes: a triple-blind randomised clinical trial
Article
Licensed
Unlicensed Requires Authentication

Efficacy of rectal progesterone on maternal and neonatal outcomes in pregnant women with Preterm Premature Rupture of membranes: a triple-blind randomised clinical trial

  • Shohre Vosoogh , Marzieh Zanganeh and Behnaz Gonabadi EMAIL logo
Published/Copyright: November 4, 2022

Abstract

Objectives

This study was conducted to evaluate the efficacy of rectal progesterone suppositories on pregnancy outcomes of pregnant women diagnosed with PPROM at the gestational age of 26–34 weeks, as well as on maternal and neonatal outcomes.

Methods

This is a double-blind, randomized clinical trial in pregnant women with PROM with gestational age of 26–24 weeks, conducted between February 2020 and December 2020 in Sayyad Shirazi Hospital, Gorgan, Iran.

Results

According to the results of the present study; Rectal progesterone suppository in pregnant women with PPROM is associated with improved delivery outcomes such as neonatal APGAR score, increased latent delivery stage without complications or severe and dangerous complications, without increased risk of mortality and NICU hospitalization in infants, so prescribing suppository rectal progesterone in pregnant women with PPROM with a gestational age of 26 to 34 weeks is associated with positive outcomes and is recommended based on the findings and opinions of the researchers.

Conclusions

According to the results of the present study; Rectal progesterone suppository in pregnant women with PPROM is associated with improved delivery outcomes such as neonatal APGAR score, increased latent delivery stage without complications or severe and dangerous complications, without increased risk of mortality and NICU hospitalization in infants, so prescribing suppository rectal progesterone in pregnant women with PPROM with a gestational age of 26 to 34 weeks is associated with positive outcomes and is recommended based on the findings and opinions of the researchers.


Corresponding author: Behnaz Gonabadi, Department of Obstetrics and Gynecology, School of Medicine, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran, E-mail:

  1. Research funding: None.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: No.

  4. Informed consent: Informed consent was obtained from all individuals

    included in this study.

  5. Ethical approval: IRCT20200610047716N1.

References

1. James, D, Steer, P, Weiner, C, Gonik, B, Robson, S. In high-risk pregnancy: management options. Cambridge: Cambridge University Press; 2017.10.1017/9781108664677Search in Google Scholar

2. Jafarpour, H, Mousavi, SJ, Mirghorbani, M, Razavi, AR, Atarod, Z. Effect of 17 α-hydroxyprogesterone caproate on the prevention of preterm labor: a randomized controlled trial study. J. midwifery reproductive health 2020;8:2317–23.Search in Google Scholar

3. Mobasheri, E, Jafarpour, H, Rezaei, A, Piraste Far, Z, Bakhshi, T. The role of antibiotics therapy on maternal complication in women with premature rupture of membranes. J Med Invest 2017;6:53–8.Search in Google Scholar

4. Medina, TM, Hill, DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Physician 2006;73:659–64.Search in Google Scholar

5. Mercer, BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178–93. https://doi.org/10.1016/s0029-7844(02)02366-9.Search in Google Scholar PubMed

6. Taghavi, S, Abam, F, Alikhah, H. Maternal-fetal and neonatal outcome in 26-32 Weeks pregnancies with preterm premature rupture of membranes (PPROM): a comparison between inpatient and outpatient management. Med J Tabriz Univ Med 2012;34:38–46.Search in Google Scholar

7. How, HY, Sibai, BM. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Therapeut Clin Risk Manag 2009;5:55.10.2147/TCRM.S1567Search in Google Scholar

8. Nuriel-Ohayon, M, Neuman, H, Koren, O. Microbial changes during pregnancy, birth, and infancy. Front Microbiol 2016;7:1031. https://doi.org/10.3389/fmicb.2016.01031.Search in Google Scholar PubMed PubMed Central

9. Abdali, F, Taghavi, S, Vazifekhah, S, Behzad, MN, Attari, MMA. Effect of progesterone on latent phase prolongation in patients with preterm premature rupture of membranes. Acta Med Iran 2017:772–8.Search in Google Scholar

10. Cunningham, F, leveno, KJ, Bloom, SL, Hauth, JC, Rouse, DJ, Spong, CY. Normal labor and delivery. New York: McGraw-Hill; 2010, 23.Search in Google Scholar

11. Briery, CM, Veillon, EW, Klauser, CK, Martin, RW, Magann, EF, Chauhan, SP, et al.. Women with preterm premature rupture of the membranes do not benefit from weekly progesterone. Am J Obstet Gynecol 2011;204:e1–5. https://doi.org/10.1016/j.ajog.2010.08.022.Search in Google Scholar PubMed

12. Combs, CA, Garite, TJ, Maurel, K, Abril, D, Das, A, Clewell, W, et al.. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 2015;213:e1–12. https://doi.org/10.1016/j.ajog.2015.05.009.Search in Google Scholar PubMed

13. Mesdaghinia, E, Mesdaghinia, A, Hashemi, T, Sooky, Z, Mousavi, SGA. Comparing the effects of Indomethacin and Magnesium-sulfate in the treatment of preterm labor. KAUMS J 2012;16:95–101.Search in Google Scholar

14. Edwards, DRV, Likis, FE, Andrews, JC, Woodworth, AL, Jerome, RN, Fonnesbeck, CJ, et al.. Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route. Arch Gynecol Obstet 2013;287:1059–66. https://doi.org/10.1007/s00404-013-2789-9.Search in Google Scholar PubMed

15. El-Refaie, W, Abdelhafez, MS, Badawy, A. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. Arch Gynecol Obstet 2016;293:61–7. https://doi.org/10.1007/s00404-015-3767-1.Search in Google Scholar PubMed

16. Mirzaei, F, Moradi, P. Effects of progesterone on latency period in patients with preterm premature rupture of membranes during 24-34 weeks of pregnancy. J Kerman Univ Med Sci 2015;22:240–8.Search in Google Scholar

17. Norman, JE, Marlow, N, Messow, C-M, Shennan, A, Bennett, PR, Thornton, S, et al.. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016;387:2106–16. https://doi.org/10.1016/s0140-6736(16)00350-0.Search in Google Scholar PubMed PubMed Central

18. Maher, MA, Abdelaziz, A, Ellaithy, M, Bazeed, MF. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone. Acta Obstet Gynecol Scand 2013;92:215–22. https://doi.org/10.1111/aogs.12017.Search in Google Scholar PubMed

Received: 2021-12-06
Accepted: 2022-07-17
Published Online: 2022-11-04

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Letter to the Editor
  3. COVID-19 pandemic: transmission of SARS-CoV-2 in animals, a risk for human beings
  4. Original Articles
  5. Anti Mullerian hormone as a diagnostic tool for polycystic ovary syndrome in women of reproductive age with morbid obesity
  6. Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6)
  7. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis
  8. Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3– independent GPx1 expression in the heart of mice with endometriosis
  9. Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients
  10. Association between TP53 Arg72Pro variant and recurrent pregnancy loss in the Greek population
  11. Selective estrogen receptor α and β antagonist aggravate cardiovascular dysfunction in type 2 diabetic ovariectomized female rats
  12. Adrenocorticotropic hormone (ACTH) level and adrenal deficiency in patients with mucocutaneous pemphigus
  13. The effect of resistance training on serum levels of sex hormones and sperm quality in male rats under X-ray radiation
  14. The effect of high-intensity interval training on serum and adipose tissues vaspin levels in rats fed a high-fat high-sucrose diet
  15. Anti-migratory effect of curcumin on A-549 lung cancer cells via epigenetic reprogramming of RECK/ matrix metalloproteinase axis
  16. Efficacy of rectal progesterone on maternal and neonatal outcomes in pregnant women with Preterm Premature Rupture of membranes: a triple-blind randomised clinical trial
  17. Case Report
  18. Ovarian tissue cryopreservation in Malaysia: a case series
  19. Review Articles
  20. An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae
  21. Potential role of melatonin in prevention and treatment of lung cancer
  22. Esketamine–A quick-acting novel antidepressant without the disadvantages of ketamine
Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2021-0103/html
Scroll to top button